Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial

Journal of Nuclear Cardiology

Volumn 17, Issue 2, 2010, Pages 286-291

  Cheng, Victor Y ^a,b   Slomka, Piotr J ^a,b   Ahlen, Marie ^a   Thomson, Louise E J ^a,b   Waxman, Alan D ^a,b   Berman, Daniel S ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbohydrates diet fatty acids 18F FDG myocardium PET

Indexed keywords

FATTY ACID; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FEMALE; HEART MUSCLE METABOLISM; HUMAN; LIPID DIET; LIVER METABOLISM; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY;

AGED; DIET; DIETARY CARBOHYDRATES; FASTING; FATTY ACIDS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 77953321764     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9179-5     Document Type: Article

References (25)

1. Engel H, Steinhart H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK. Whole body PET: Physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441-6.
2. Shreve P, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics 1999;19:61-77.
3. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131-8.
4. van der Wal AC, Das PK, Bentz van de Berg D, van der Loos CM, Becker AE. Atherosclerotic lesions in humans: In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989;61:166-70.
5. Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. (18)F-FDG accumulation in atherosclerotic plaques: Immunohistochemical and PET imaging study. J Nucl Med 2004;45: 1245-50.
6. Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47:C57-68.
7. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: A new observation. Clin Nucl Med 2001;26:314-9.
8. 18F]- fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11.
9. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation inpatients. J Am Coll Cardiol 2006;48:1818-24.
10. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: Implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50:892-6.
11. Lum DP, Wandell S, Ko J, Coe MN. Reduction of myocardial fluorodeoxyglucose uptake artifacts with a carbohydrate restricted diet. Clin Positron Imaging 2000;3:155.
12. Lum DP, Wandell S, Ko J, Coel MN. Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. Mol Imaging Biol 2002;4:232-7.
13. 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. Am J Roentgenol 2008;190:W151-6.
14. Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50:563-8.
15. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart II. Studies on fat, ketone and amino acid metabolism. Am J Med 1954;16:504-15.
16. Opie LH, Evans JR, Shipp JC. Effect of fasting on glucose and palmitate metabolism of perfused rat heart. Am J Physiol 1963;205:1203-8.
17. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36:413-59.
18. Wisneski JA, Gert EW, Neese RA, Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest 1987;79:359-66.
19. Frayn KN. The glucose-fatty acid cycle: A physiological perspective. Biochem Soc Trans 2003;31:1115-9.
20. Yamanouchi M, Yoshia K, Niwayama H, Nakagawa K, Aioi S, Shikama N, et al. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males. Jpn Circ J 1996;60:319-27.
21. Thomas TR, Fischer BA, Kist WB, Horner KE, Cox RH. Effects of exercise and n-3 fatty acids on postprandial lipemia. J Appl Physiol 2000;88:2199-204.
22. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971;50:1386-9.
23. Kjekshus JK, Mjos OD. Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest 1972;51:1767-76.
24. Mjos OD, Kjekshus JK, Lekvan J. Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. J Clin Invest 1974;53:1290-9.
25. Vik-Mo H, Mjos OD. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am J Cardiol 1981;48: 361-5.